Capula Management Ltd bought a new position in Globe Life Inc. (NYSE:GL – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 14,006 shares of the company’s stock, valued at approximately $2,002,000.
A number of other institutional investors have also modified their holdings of GL. Mather Group LLC. bought a new position in Globe Life in the third quarter worth approximately $28,000. CYBER HORNET ETFs LLC bought a new stake in Globe Life during the 2nd quarter valued at $28,000. MUFG Securities EMEA plc bought a new stake in Globe Life during the 2nd quarter valued at $31,000. Quent Capital LLC purchased a new stake in shares of Globe Life in the 3rd quarter worth $36,000. Finally, AlphaCore Capital LLC grew its position in shares of Globe Life by 1,557.1% during the 2nd quarter. AlphaCore Capital LLC now owns 348 shares of the company’s stock worth $43,000 after buying an additional 327 shares in the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Globe Life
In related news, Director Mark A. Blinn sold 1,750 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $147.91, for a total value of $258,842.50. Following the completion of the transaction, the director directly owned 3,372 shares of the company’s stock, valued at $498,752.52. This trade represents a 34.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO James Matthew Darden sold 18,318 shares of Globe Life stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total transaction of $2,657,941.80. Following the completion of the sale, the chief executive officer owned 51,093 shares of the company’s stock, valued at $7,413,594.30. This trade represents a 26.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 92,186 shares of company stock valued at $13,358,379. Insiders own 1.51% of the company’s stock.
Globe Life Stock Performance
Globe Life (NYSE:GL – Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the business earned $3.14 EPS. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.
Globe Life Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be issued a $0.33 dividend. This is a boost from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Thursday, April 2nd. Globe Life’s dividend payout ratio is 9.38%.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the company. Evercore set a $157.00 price target on Globe Life in a research note on Wednesday, February 18th. Truist Financial upped their price objective on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, February 6th. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. Morgan Stanley restated an “overweight” rating and issued a $176.00 price target on shares of Globe Life in a report on Monday, December 15th. Finally, JPMorgan Chase & Co. upped their price target on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Eight analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $171.33.
Check Out Our Latest Analysis on GL
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Stories
- Five stocks we like better than Globe Life
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
